# VPRIV

NDC: 54092-701
Generic name: velaglucerase alfa
Labeler / Manufacturer: Takeda Pharmaceuticals America, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20100226

FDA application: BLA022575

## Active ingredients

- VELAGLUCERASE ALFA: 2.5 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"54092-701"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=54092-701
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ca02f7a4-ae4f-43c1-a06a-259fe4fcf9cf